Navigation Links
NephRx Corp. Receives Orphan Drug Designation for NX001 for Prevention of Delayed Kidney Graft Function
Date:8/18/2010

KALAMAZOO, Mich., Aug. 18 /PRNewswire/ -- NephRx Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its lead product NX001 for the prevention of delayed graft function (DGF) in renal transplant recipients.  NX001 is a kidney growth factor peptide that has demonstrated good safety and promising efficacy in two animal models of acute renal failure.  

"Delayed graft function is a common condition affecting many kidney transplant patients, but current treatment options are limited," said James Koziarz, Ph.D., CEO of NephRx Corp.  "NX001 has demonstrated promising activity in improving kidney function in preclinical models of acute renal failure, and we look forward to initiation later this year of our clinical program to test its effectiveness in helping patients achieve better kidney function post-transplant."

DGF affects an estimated 20-25% of the approximately 14,000 renal transplants performed annually in the U.S.  Currently, there is no treatment for DGF.  DGF patients are put on dialysis to "rest" the transplanted kidney, correct metabolic imbalances and wait for kidney function to return spontaneously.  Studies have shown that DGF can negatively affect future graft function and can increase the incidence of acute rejection episodes.  Kidney grafts with impaired function require the most intense follow-up and therapeutic management and are economically most costly.  

"NX001 is an entirely new approach to treating acute kidney dysfunction," noted F. Gary Toback, M.D., Ph.D., Founding Scientist of NephRx and Professor of Medicine and Cell Physiology at the University of Chicago Medical School.  "The kidney is one of the few human organs with the potential for self-repair, and we believe a kidney growth factor peptide such as NX001 has the potential to stimulate improved renal functioning in a number of renal disorders.  DGF repre
'/>"/>

SOURCE NephRx Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
2. InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008
3. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008
4. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
5. Aegis Analytical Corp. Showcases Discoverant at Inaugural Venture Capital in the Rockies Fall
6. BioElectronics Corp. Announces $400,000 in New Orders From the Middle East
7. BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Directors
8. Cantel Medical Corp. To Hold Conference call to Discuss Fourth Quarter and Fiscal 2008 Results
9. Helix BioPharma Corp. Announces Fiscal 2008 Results
10. Sharps Compliance Corp. Announces Appointment of John R. Grow as President and Chief Operating Officer
11. ThermoGenesis Corp. to Announce First Quarter Fiscal 2009 Results on November 6, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... company focused on the development of autologous cell ... Phase 1/2 clinical trial of RCT-01, being tested ... has been enrolled and their tissue biopsy sent ... is comprised of non-bulbar dermal sheath (NBDS) cells ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... 14. She has accepted the position of vice president of instruction at Chippewa ... , “I greatly appreciated the opportunity to lead SIUE during the past ...
(Date:6/30/2015)... ... June 30, 2015 , ... Cannavoices , ... an unprecedented digital video and broadcast initiative. Produced by filmmakers, the multi-platform initiative ... of legal medical cannabis stories ever assembled. , Cannavoices profiles Advocates, Patients, ...
(Date:6/29/2015)... 2015   Pharnext SAS today announced that data ... treatment of Charcot-Marie-Tooth Type 1A (CMT1A), is being presented in ... Nerve Society (PNS) Biennial Meeting at the Quebec Congress Center ... - July 2, 2015. At Poster Viewing Session ... 5p.m. to 7p.m. EDT: Poster 23: "A ...
Breaking Biology Technology:RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 2SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 3Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 2Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 3Pharnext's PXT-3003 Featured in Multiple Presentations at 2015 Peripheral Nerve Society Biennial Meeting 2
... PharmAthene, Inc.,(Amex: PIP ) a biodefense ... announced that the Delaware Chancery Court,today issued a ... dismiss,PharmAthene,s complaint, which alleges that it has a ... SIGA,s drug candidate, SIGA-246. SIGA,s,request to dismiss the ...
... Helix BioPharma Corp.,(TSX: HBP/Frankfurt: WKN 918846) announced today ... Inc. ("KBI") to develop a process for,preparing L-DOS47 ... clinical testing., "This new arrangement advances the ... with L-DOS47," said John Docherty, Helix,s,president. "The lyophilized ...
... Bristol-Myers Squibb,Company (NYSE: BMY ) will announce ... on Thursday, January 31. During a 10 a.m. (ET) ... information and will,address inquiries from investors and analysts., ... to a live,webcast of the call at http://www.bms.com/ir ...
Cached Biology Technology:Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthene's Legal Action in Breach of Contract Lawsuit Against SIGA 2Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format 2Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format 3
(Date:6/10/2015)... June 10, 2015 According ... Market by Technology (Ultrasound, TOF, Structured Light, Stereo ... Entertainment, Automotive) and by Geography - Trends & ... the market is expected to reach $3,319.71 Million ... between 2015 and 2020. Browse 71 ...
(Date:6/9/2015)... DUBLIN , June 09, 2015 ... the addition of the "Gesture Recognition & ... Application (Consumer Electronics, Automotive, & Others), Product (Biometric ... Forecast to 2020" report to their offering. ... sensing market is expected to reach $ 23.55 ...
(Date:6/8/2015)... 2015  The Secure Identity & Biometrics ... Troy Potter of L-3 National Security ... a non-profit association that was established in February ... implementation of solutions that protect and secure identity ... Photo - ...
Breaking Biology News(10 mins):3D Sensor Market Worth $3,319.71 Million by 2020 23D Sensor Market Worth $3,319.71 Million by 2020 33D Sensor Market Worth $3,319.71 Million by 2020 4Global Gesture Recognition & Touchless Sensing (Technology, Application & Products) Market 2015-2020 2Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 2Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 3Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 4Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 5
... Researchers at Washington University in St. Louis have figured ... complex to its neighboring membrane in a photosynthetic bacterium, ... in photosynthesis. Robert Blankenship, Ph.D., Markey Distinguished Professor ... a team that for the first time combined chemical ...
... -- Three leading research centers based in Woods Hole, ... a new alliance that will bring their combined scientific ... facing society today and spawn scientific growth and job ... consortium comprises the Woods Hole Marine Biological Laboratory (MBL), ...
... that appears to prevent some men from conceiving children ... according to University of Iowa researchers reporting their findings ... American Journal of Human Genetics . Although female ... have proven very effective for family planning, no similar ...
Cached Biology News:Orientation of antenna protein in photosynthetic bacteria described 2Orientation of antenna protein in photosynthetic bacteria described 33 Woods Hole scientific institutions forge alliance to address societal issues 23 Woods Hole scientific institutions forge alliance to address societal issues 3Gene discovery could lead to male contraceptive 2
Request Info...
Bovine Serum Albumin Heat Shock Diagnostic Grade Powder...
... provides the premium quality siRNAs you need ... can be readily ordered online by providing ... by providing the sense and antisense siRNA ... Validated and Silencer Pre-designed ...
... siRNA service provides the premium quality siRNAs ... Custom siRNAs can be readily ordered online ... sequence, or by providing the sense and ... Silencer Validated and Silencer ...
Biology Products: